Detalhe da pesquisa
1.
Association between Acute Declines in Estimated Glomerular Filtration Rate during Renin-Angiotensin System Inhibition and Risk of Adverse Outcomes.
J Am Soc Nephrol
; 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38889197
2.
A meta-analysis of randomized controlled clinical trials implications of acute treatment effects on glomerular filtration rate for long-term kidney protection.
Kidney Int
; 2024 Jun 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-38901604
3.
Sotagliflozin in Patients with Diabetes and Recent Worsening Heart Failure.
N Engl J Med
; 384(2): 117-128, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200892
4.
Sotagliflozin in Patients with Diabetes and Chronic Kidney Disease.
N Engl J Med
; 384(2): 129-139, 2021 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-33200891
5.
Change in Albuminuria and GFR Slope as Joint Surrogate End Points for Kidney Failure: Implications for Phase 2 Clinical Trials in CKD.
J Am Soc Nephrol
; 34(6): 955-968, 2023 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36918388
6.
Acute Treatment Effects on GFR in Randomized Clinical Trials of Kidney Disease Progression.
J Am Soc Nephrol
; 33(2): 291-303, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-34862238
7.
Multinephron Segment Diuretic Therapy to Overcome Diuretic Resistance in Acute Heart Failure: A Single-Center Experience.
J Card Fail
; 28(1): 21-31, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34403831
8.
Effect of Sotagliflozin on Total Hospitalizations in Patients With Type 2 Diabetes and Worsening Heart Failure : A Randomized Trial.
Ann Intern Med
; 174(8): 1065-1072, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34152828
9.
Impact of Using the Race-Free 2021 CKD-EPI Creatinine Equation on Treatment Effects on GFR-Based End Points in Clinical Trials.
Am J Kidney Dis
; 83(2): 269-272, 2024 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-37657637
10.
Correction to: Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end-stage renal disease.
J Behav Med
; 42(2): 376-379, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30623275
11.
"Dip" in eGFR: Stay the Course With SGLT-2 Inhibition.
Circulation
; 146(6): 463-465, 2022 08 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35939546
12.
Update on Diabetic Nephropathy: Core Curriculum 2018.
Am J Kidney Dis
; 71(6): 884-895, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29398179
13.
Effects of Intensive Blood Pressure Treatment on Acute Kidney Injury Events in the Systolic Blood Pressure Intervention Trial (SPRINT).
Am J Kidney Dis
; 71(3): 352-361, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29162340
14.
Anti-TGF-ß1 Antibody Therapy in Patients with Diabetic Nephropathy.
J Am Soc Nephrol
; 28(3): 953-962, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27647855
15.
The safety of achieved iron stores and their effect on IV iron and ESA use: post-hoc results from a randomized trial of ferric citrate as a phosphate binder in dialysisâ©.
Clin Nephrol
; 87 (2017)(3): 124-133, 2017 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-28128726
16.
Managing Hypertension in Patients with CKD: A Marathon, Not a SPRINT.
J Am Soc Nephrol
; 27(1): 40-3, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26553785
17.
Health care providers' support of patients' autonomy, phosphate medication adherence, race and gender in end stage renal disease.
J Behav Med
; 39(6): 1104-1114, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27167227
18.
Ferric Citrate Reduces Intravenous Iron and Erythropoiesis-Stimulating Agent Use in ESRD.
J Am Soc Nephrol
; 26(10): 2578-87, 2015 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25736045
19.
Ferric citrate controls phosphorus and delivers iron in patients on dialysis.
J Am Soc Nephrol
; 26(2): 493-503, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25060056
20.
Serum Bicarbonate and Kidney Disease Progression and Cardiovascular Outcome in Patients With Diabetic Nephropathy: A Post Hoc Analysis of the RENAAL (Reduction of End Points in Non-Insulin-Dependent Diabetes With the Angiotensin II Antagonist Losartan) Study and IDNT (Irbesartan Diabetic Nephropathy Trial).
Am J Kidney Dis
; 66(3): 450-8, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-25987260